|
1
|
Bacci G, Ferrari S, Bertoni F, et al:
Long-term outcome for patients with nonmetastatic osteosarcoma of
the extremity treated at the istituto ortopedico rizzoli according
to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an
updated report. J Clin Oncol. 18:4016–4027. 2000.
|
|
2
|
Brozovic A and Osmak M: Activation of
mitogen-activated protein kinases by cisplatin and their role in
cisplatin-resistance. Cancer Lett. 251:1–16. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gorlick R, Anderson P, Andrulis I, et al:
Biology of childhood osteogenic sarcoma and potential targets for
therapeutic development: meeting summary. Clin Cancer Res.
9:5442–5453. 2003.PubMed/NCBI
|
|
4
|
Reggiori F and Klionsky DJ: Autophagy in
the eukaryotic cell. Eukaryot Cell. 1:11–21. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Codogno P and Meijer AJ: Autophagy and
signaling: their role in cell survival and cell death. Cell Death
Differ. 12(Suppl 2): 1509–1518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levine B and Yuan J: Autophagy in cell
death: an innocent convict? J Clin Invest. 115:2679–2688. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krysko DV and Vandenabeele P: From
regulation of dying cell engulfment to development of anti-cancer
therapy. Cell Death Differ. 15:29–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Degenhardt K, Mathew R, Beaudoin B, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amaravadi RK, Yu D, Lum JJ, et al:
Autophagy inhibition enhances therapy-induced apoptosis in a
Myc-induced model of lymphoma. J Clin Invest. 117:326–336. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rosenfeldt MT and Ryan KM: The role of
autophagy in tumour development and cancer therapy. Expert Rev Mol
Med. 11:e362009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin S and White E: Tumor suppression by
autophagy through the management of metabolic stress. Autophagy.
4:563–566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Donovan TR, O'Sullivan GC and McKenna
SL: Induction of autophagy by drug-resistant esophageal cancer
cells promotes their survival and recovery following treatment with
chemotherapeutics. Autophagy. 7:509–524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun WL, Chen J, Wang YP and Zheng H:
Autophagy protects breast cancer cells from epirubicin-induced
apoptosis and facilitates epirubicin-resistance development.
Autophagy. 7:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Seibenhener ML, Geetha T and Wooten MW:
Sequestosome 1/p62 - more than just a scaffold. FEBS Lett.
581:175–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Komatsu M, Kurokawa H, Waguri S, et al:
The selective autophagy substrate p62 activates the stress
responsive transcription factor Nrf2 through inactivation of Keap1.
Nat Cell Biol. 12:213–223. 2010.PubMed/NCBI
|
|
17
|
Bjorkoy G, Lamark T and Johansen T:
p62/SQSTM1: a missing link between protein aggregates and the
autophagy machinery. Autophagy. 2:138–139. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kirkin V, McEwan DG, Novak I and Dikic I:
A role for ubiquitin in selective autophagy. Mol Cell. 34:259–269.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shvets E, Fass E, Scherz-Shouval R and
Elazar Z: The N-terminus and Phe52 residue of LC3 recruit
p62/SQSTM1 into autophagosomes. J Cell Sci. 121:2685–2695. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Linares JF, Amanchy R, Greis K, Diaz-Meco
MT and Moscat J: Phosphorylation of p62 by cdk1 controls the timely
transit of cells through mitosis and tumor cell proliferation. Mol
Cell Biol. 31:105–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kabeya Y, Mizushima N, Ueno T, et al: LC3,
a mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bjorkoy G, Lamark T, Brech A, et al:
p62/SQSTM1 forms protein aggregates degraded by autophagy and has a
protective effect on huntingtin-induced cell death. J Cell Biol.
171:603–614. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Solomon VR and Lee H: Chloroquine and its
analogs: a new promise of an old drug for effective and safe cancer
therapies. Eur J Pharmacol. 625:220–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tanida I, Minematsu-Ikeguchi N, Ueno T and
Kominami E: Lysosomal turnover, but not a cellular level, of
endogenous LC3 is a marker for autophagy. Autophagy. 1:84–91. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kaini RR and Hu CA: Synergistic killing
effect of chloroquine and androgen deprivation in LNCaP cells.
Biochem Biophys Res Commun. 425:150–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sasaki K, Tsuno NH, Sunami E, et al:
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on
colon cancer cells. BMC Cancer. 10:3702010. View Article : Google Scholar : PubMed/NCBI
|
